COVID-19 information, guidance, and resources. Information about campus return and fall quarter planning. Additional health guidance available on the CDC's COVID-19 site.
University of California, Riverside
UC Riverside-led study is the first to show how tofacitinib rescues gut barrier function from overactive immune cells
UC Riverside mouse study will identify mechanisms the gene PTPN2 uses to affect gut cells
UC Riverside-led study is the first to show how tofacitinib affects epithelial cells lining the gut
UC Riverside-led study tested the effects of microgravity on intestinal epithelial cells